Multiple Sklerose Therapie Konsensus Gruppe (MSTKG): Positionspapier zur verlaufsmodifizierenden Therapie der Multiplen Sklerose 2021 (White Paper)

URN to cite this document:: urn:nbn:de:bvb:355-epub-566437
DOI to cite this document:: 10.5283/epub.56643

Wiendl, Heinz ; Gold, Ralf ; Berger, Thomas ; Derfuss, Tobias ; Linker, Ralf A. ; Mäurer, Mathias ; Stangel, Martin ; Aktas, Orhan ; Baum, Karl ; Berghoff, Martin ; Bittner, Stefan ; Chan, Andrew ; Czaplinski, Adam ; Deisenhammer, Florian ; Di Pauli, Franziska ; Du Pasquier, Renaud ; Enzinger, Christian ; Fertl, Elisabeth ; Gass, Achim ; Gehring, Klaus ; Gobbi, Claudio ; Goebels, Norbert ; Guger, Michael ; Haghikia, Aiden ; Hartung, Hans‑Peter ; Heidenreich, Fedor ; Hoffmann, Olaf ; Hunter, Zoë R. ; Kallmann, Boris ; Kleinschnitz, Christoph ; Klotz, Luisa ; Leussink, Verena ; Leutmezer, Fritz ; Limmroth, Volker ; Lünemann, Jan D. ; Lutterotti, Andreas ; Meuth, Sven G. ; Meyding-Lamadé, Uta ; Platten, Michael ; Rieckmann, Peter ; Schmidt, Stephan ; Tumani, Hayrettin ; Weber, Martin S. ; Weber, Frank ; Zettl, Uwe K. ; Ziemssen, Tjalf ; Zipp, Frauke

License: Creative Commons Attribution 4.0
PDF - Published Version
(1MB)

Date of publication of this fulltext: 29 Feb 2024 12:35

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Multiple sclerosis is a complex, autoimmune-mediated disease of the central nervous system characterized by inflammatory demyelination and axonal/neuronal damage. The approval of various disease-modifying therapies and our increased understanding of disease mechanisms and evolution in recent years have significantly changed the prognosis and course of the disease. This update of the Multiple ...